Before heading into administration, Advanced Oncotherapy (AVO) managed to rack up liabilities of almost £70 million. So how would you like to own the assets and businesses which achieved such monumental value destruction as the management lived high on the hog? As you can see below, now is your chance! Come on what's stopping you?
Slung off the AIM Casino more than five months after it should have been, no cash, borrowings and other liabilities of £60 million, no refinancing no accounts since H1 2022, Advanced Oncotherapy (AVO) looks like a dead duck, walks like a dead duck and quacks like a dead duck. And….
After all the lying to investors, untrue RNS’s, insider dealing and management greed as fully exposed on this website over many years, Advanced Oncotherapy (AVO) has today been booted off the AIM Casino. At last I can shout Gotcha!
Oh dear, oh dear. We still have no refinancing, interims, prelims and shares in Advanced Oncotherapy (AVO), which should have been slung off Aim on January 1 remain there and suspended. As AIM Regulation does not give a flying feck about its own rules ( in this case Rule 19), why should anyone else? Today there is more bad news.
Aim-listed Advanced Oncotherapy (AVO) should have been sent for a one-way trip to the AIM Executioner at the end of December. Yet first in January, then in February, and now at the beginning of April, AIM has broken its own rules in not enforcing that outcome. What is the point of rules?
For having their shares suspended for more than six months because of a failure to publish interim and full year accounts, Advanced Oncotherapy (AVO) and Live Company (LVCG) should have been booted off the AIM sewer on January 1 and February 1 (today) respectively. But on the “world’s most successful growth market” it seems that rules just do not matter. Or perhaps because it is shrinking so rapidly, the regulators will not boot anyone off. In both cases, the companies are – as things stand – insolvent.
I am not talking about imaginary rules dreamt up by the wretched poltroon Giles Balleny at Cavendish and the bearded buffoon Stuart Ashman but real AIM Rules, specifically the one that if shares are suspended for more than six months because of a failure to publish accounts, those shares are slung off AIM. But sometimes they are not. I have written to the Oxymorons at AIM regulation regarding Advanced Oncotherapy (AVO), where I own 1 share allowing me to attend AGMs but have been a perennial bear.
Communications over the past couple of days with the Oxymorons at AIM Regulation, the minions of Marcus Stuttard, have at least forced a statement and adman depressing one from Advanced Oncotherapy (AVO). But the Oxymorons still will not boot it off the sewer as they should have done on December 31. What is the point of rules that are just not enforced?
AIM-listed crock Advanced Oncotherapy (AVO) which is already suspended served up an update on its financing this morning. It makes utterly grim reading: time to order in a huge delivery of Ouzo for Christmas.
AIM-listed crock Advanced Oncotherapy (AVO), currently suspended pending financial clarification and unable to produce its accounts, has announced prospective recapitalisation plans which include a death spiral, debt-for-equity conversions and a general shafting of the current equity holders. And the plans are clearly at an aspirational level, dependent as they are on new equity capital being made available, approval from the takeover panel, the agreement of creditors and shareholders too. The choice seems to be maybe almost death, or just death.
At Sheriff and Deputy Sheriff Towers it is lashings of ouzo on the cornflakes today as Advanced Oncotherapy (AVO) has suspended its shares pending clarification of its financial position. That won’t take long: it’s bust! Folks really cannot say that both the Sheriffs did not warn the that this would end in tears more than 300 times over so many years as you can see HERE
AIM-listed Advanced Oncotherapy (AVO) shares fell to just 2.375p per share on Friday as Odey Asset Management continued to dump the shares at any price it can get, having paid 25p for shares trading in the market for less. We warned you this was coming and with still 49 million bits of confetti to offload, there is more to come.
Shares in AIM-listed calamity Advanced Oncotherapy (AVO) fell to just 2.875p per share yesterday, just ahead of its low point in March, as Odey Asset Management (now minus Mr Odey banned by the FCA as a sex pest) was announced to have been dumping stock. Given that Odey still has around 10% of the company, this is calamitous news for shareholders – and much worse for Odey’s clients.
Following this piece from Tom Winnifrith yesterday noting the collapsing shares in AIM-listed dog Advanced Oncotherapy (AVO), the company issued a statement at 5.57pm – no-one-is-watching o’clock. The suspicious cynic might be drawn to an inevitable conclusion.
Is it not time for an update from Advanced Oncotherapy (AVO)? Comrade Evil Banksta who is short has dropped me a short note which seems perfectly sensible to me.
